Jump to content
  • Sign Up
Sign in to follow this  

Fifteen Minute Test May Save 15% or More on Rosacea Treatment

Recommended Posts


Rosacea is a common inflammatory skin condition that impacts a large portion of fair-skinned populations. The redness associated with rosacea can be a significant challenge. Brimonidine sulfate and oxymetazoline HCL were both recently approved by the FDA for the management of facial redness. These agents, however, are costly, and not all patients respond to the medication. Herein, we describe a clinical pearl that helps to optimize patient selection for the medications. This saves the patient and the health care system both time and money. 

Fifteen Minute Test May Save 15% or More on Rosacea Treatment, Journal of Drugs in Dermatology, 2018;17(5):692-693
June 2018 | Volume 17 | Issue 6 | Department | 692 | Copyright © 2018
Evan Darwin BA, Jessica Cervantes BA, and Hadar Lev-Tov MD
University of Miami Miller School of Medicine, Miami, FL

Share this post

Link to post
Share on other sites

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Sign in to follow this  

  • Create New...